LigaChem Biosciences

141080.KQ

134.63 USD

4.81

+3.71%

Overview

Last close

134.63 usd

Market cap

4.90B usd

52 week high

146.05 usd

52 week low

61.02 usd

Target price

145.31 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

44.5947

Price/Book Value

10.6411

Enterprise Value

3.61B usd

EV/Revenue

33.5797

EV/EBITDA

54.3204

Key financials

Revenue TTM

107.64M usd

Gross Profit TTM

96.75M usd

EBITDA TTM

-27.92M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

499.34M usd

Net debt

N/A usd

About

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.